Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 47366901000001117 | Agenerase (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 47367001000001118 | Agenerase | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agenerase | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Agenerase 150mg capsules (GlaxoSmithKline) | Is a | True | Agenerase | Inferred relationship | Existential restriction modifier | |
| Agenerase 15mg/ml oral solution (GlaxoSmithKline) | Is a | True | Agenerase | Inferred relationship | Existential restriction modifier | |
| Agenerase 50mg capsules (GlaxoSmithKline) | Is a | True | Agenerase | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR